Skip to content
Study details
Enrolling now

Understanding and Addressing Disparities in Cancer Therapy Induced Inflammation and Associated Endothelial Dysfunction

Medical College of Wisconsin
NCT IDNCT05223322ClinicalTrials.gov data as of Apr 2026
Target enrollment

80

Study length

about 4.3 years

Ages

18–100

Sex

Female only

Locations

2 sites in IL, WI

What this study is about

This trial is testing a treatment called Taking Charge during Treatment (TCT) to see if it helps with inflammation and problems with blood vessels caused by cancer treatment. The goal is to learn more about how cancer treatments affect blood vessel health, specifically in women.

Simplified from trial records by PatientMatch.

What you may be asked to do

  • 1.Participate in Taking Charge during Treatment (TCT) Intervention

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
Standard

How treatment is administered

Treatment Assignment
Randomized (Open Label)

You are randomly assigned, but you will know your treatment.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Endpoints

Secondary: Cardiac function - Pulse Wave Velocity, Cognitive Function, Cytokine analysis, Endothelial function, Flow Mediated Dilation, Hospital Anxiety and Depression Scale, PROMIS - Pain Interference, PROMIS - Social Support

Body systems

Oncology